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Abstract
Research on flavonoids from plant sources has recently sparked increasing interest 
because of their beneficial health properties. Different studies have shown that 
flavonoids change the intracellular Ca2+ homeostasis linked to alterations in the function 
of mitochondria, Ca2+ channels and Ca2+ pumps. These findings hint at plasma 
membrane Ca2+-ATPase (PMCA) involvement, as it transports Ca2+ actively to the 
extracellular medium coupled to ATP hydrolysis, thus maintaining ion cellular 
homeostasis. The present study aims to investigate the effect of several natural 
flavonoids on PMCA both in isolated protein systems and in living cells, and to establish 
the relationship between flavonoid structure and inhibitory activity on PMCA. 
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Our results show that natural flavonoids inhibited purified and membranous PMCA with 
different effectiveness: quercetin and gossypin were the most potent and their inhibition 
mechanisms seem to be different, as quercetin does not prevent ATP binding whereas 
gossypin does. Moreover, PMCA activity was inhibited in human embryonic kidney cells 
which transiently overexpress PMCA, suggesting that the effects observed on isolated 
systems could occur in a complex structure like a living cell. In conclusion, this work 
reveals a novel molecular mechanism through which flavonoids inhibit PMCA, which 
leads to Ca2+ homeostasis and signaling alterations in the cell.
Keywords
Plasma membrane calcium pump, natural flavonoids, quercetin, gossypin, inhibition 
mechanism
1. Introduction
Flavonoids are natural compounds synthesized in plants by the phenylpropanoid 
pathway [1]. Due to their abundance in plants and vegetables, some flavonoids reach 
micromolar concentrations in human blood plasma [2]. Several studies have reported 
flavonoids anti-oxidative, anti-inflammatory, anti-mutagenic, and anti-carcinogenic 
properties, coupled with their capacity to modulate key cellular enzyme functions [3–8]. 
The chemical nature of flavonoids depends on their structural class, degree of 
hydroxylation, other substitutions and conjugations, and degree of polymerization. The 
biochemical activity of flavonoids depends on their chemical structure. In particular, 
quercetin ((2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one), which is 
widely distributed in several vegetables and fruits (particularly onions, peppers, 
cranberries, blueberries, apples, cherries and grapes [9]), has extensive biological 
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activity related with the prevention of cancer, diabetes, asthma, hypertension and 
cardiovascular diseases [9–13]. Other flavone derivative such as gossypin (2-(3,4-
dihydroxyphenyl)-3,5,7-trihydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6 
(hydroxymethyl)oxan-2-yl]oxychromen-4-one), which naturally occurs in various plants 
belonging to the family of Malvaceae [14], is reported to have antioxidant, anti-
inflammatory, anticonvulsant and anti-cancer activity [15–18].
Intracellular calcium (Ca2+) is tightly regulated. Cells display different mechanisms to 
maintain the low free Ca2+ concentrations (100-200 nM) needed to regulate its targets 
with optimal effectiveness. In non-excitable cells and under certain stimuli, Ca2+ release 
is induced from the endoplasmic reticulum (ER) Ca2+ stores, leading to a rise in 
intracellular Ca2+ which depletes the ER and induces the activation of store-
operated channels (SOCs) [19]. This ion excess is removed from the cytoplasm through 
different mechanisms that include transport systems at the plasma membrane level 
(e.g. Ca2+-ATPases, Na+/Ca+ exchanger) and at certain intracellular organelle 
membranes (e.g. Sarco/endoplasmic reticulum Ca2+-ATPase, SERCA). Evidence has 
shown flavonoids involvement in changes in intracellular Ca2+ concentration [20,21], 
which could be associated to their effect on Ca2+ transport systems [22,23].
Several studies suggest that certain flavonoids can inhibit a variety of ATPases, such as 
the oligomycin-sensitive mitochondrial F0/F1-ATPase, the Na+/K+-ATPase, the H+/K+-
ATPase, and the Ca2+-ATPases [22–27]. This inhibition may result from the interaction 
between flavonoids and the ATP binding sites on the protein, similarly to that observed 
in their interaction with kinases [28,29]. Some flavonoids have also been shown to 
inhibit SERCA, which could be related to the induction of apoptosis in cancer cells. 
Ogunbayo et al. [22] have suggested that apoptosis starts via the Ca2+-dependent 
mitochondrial pathway, which can be activated through a sharp increase in cytosolic 
Ca2+. This hypothesis is in agreement with the fact that certain flavonoids can induce 
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Ca2+ release from sarcoplasmic reticulum intracellular stores [30]. On the other hand, 
studies in HepG2 hepatoma cells show that quercetin induces a rise in intracellular Ca2+ 
which leads to autophagy [21]. In human breast cancer cells MDA-MB-231, quercetin 
also induces apoptosis by ER stress increasing cytosolic Ca2+ [20]. This evidence 
supports the idea that some flavonoids are related to changes in intracellular Ca2+ 
concentration and suggests that Ca2+ transport could be affected. However, the 
molecular mechanisms underlying these effects are still unclear.
The plasma membrane Ca2+ pump (PMCA) and SERCA are essential in the 
maintenance of low intracellular Ca2+ concentrations in most eukaryotic cells, as they 
use the energy obtained from ATP hydrolysis to transport Ca2+ from the cytoplasm to 
the extracellular medium or the reticulum lumen, respectively. As described above, 
SERCA can be inhibited by some natural flavonoids; however, the effect of these 
compounds on PMCA has not been established yet.
PMCA belongs to the P-type ATPase family, as it presents an acid-stable 
phosphorylated intermediate form during its reaction cycle. In humans, PMCAs are 
coded by four genes (PMCA 1–4), and additional isoforms are generated via alternative 
RNA splicing, which adds more isoform diversity [31]. The current kinetic model 
proposes that the enzyme exists in two main conformations, E1 and E2 (Figure 1). After 
the binding of intracellular Ca2+ to high-affinity sites, E1 can be phosphorylated by ATP 
with formation of the intermediate E1P, which results in occlusion of bound Ca2+. After a 
conformational transition to E2P, Ca2+ is released to the extracellular medium from low-
affinity sites, followed by the hydrolysis of the phosphoenzyme to E2 and a new 
conformational transition to E1 [32,33].
In this context, the present study aims to investigate the effect of different natural 
flavonoids on human PMCA isoform 4 (hPMCA4) activity. hPMCA4 is the most 
abundant in red blood cells and the most tightly regulated isoform, as well as being 
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ubiquitously distributed across tissues [31,34]. Thus, Ca2+-ATPase activity was 
measured in the presence of several flavonoids selected on the basis of their 
correspondence to different basic structure types with varied substitutions (flavanone, 
flavone, flavonol, chalcone, aglycones and/or glycosides, Table 1), using purified 
hPMCA4 and sealed inside-out vesicle (IOV) systems obtained from human 
erythrocytes. Results show that flavonols quercetin and gossypin were the most potent 
inhibitors from this series of flavonoids. Moreover, our studies demonstrate that these 
compounds showed different mechanisms of inhibition. Additionally, the study of 
flavonoids effects on the activity of transiently overexpressed hPMCA4 in human 
embryonic kidney cells HEK293T also shows inhibition by both quercetin and gossypin.
2. Materials and Methods
2.1. Chemicals 
HEK293T cells were obtained from American Type Culture Collection (ATCC, 
Manassas, VA). Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum 
(FBS), Lipofectamine LTX Reagent with PLUS Reagent and cell culture supplements 
were purchased from Invitrogen-Thermo Fisher Scientific (Carlsbad, CA, USA). 
Antibiotic/antimycotic solution was obtained from Life Technologies Inc. (Carlsbad, CA, 
USA). The fluorescent probe Fluo-4-AM was obtained from Molecular Probes (Eugene, 
OR, USA). PVDF blot membrane was obtained from BioRad Laboratories (Reinach, 
Switzerland). Anti-PMCA primary mouse monoclonal antibody 5F10 was from Thermo 
Fisher Scientific. Dimyristoyl phosphatidylcholine (DMPC) was from Avanti Lipids 
(Alabaster, AL, USA). Gossypin, flavanone and chalcone were obtained from 
Extrasynthese (Genay, France). Thapsigargin (TG), hesperidin, naringin, rutin, 
hesperetin, flavone, diosmetin, quercetin, apigenin, chrysin, 6-methylflavone, hesperidin 
methyl chalcone, kaempferol, galangin and hyperoside, polyoxyethylene (10) lauryl 
ether (C12E10) and all the other chemicals used in this work were of analytical grade and 
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were purchased from Sigma-Aldrich (St. Louis, MO, USA). Human blood recently drawn 
at Fundación Fundosol (Buenos Aires, Argentina) was used for the isolation of PMCA. 
Donors provided informed consent for the donation of blood and for its subsequent 
legitimate use by the transfusion service. 
2.2. Preparation of erythrocyte inside-out vesicles (IOVs) 
IOVs were prepared from human erythrocyte plasma membrane as described 
previously [35]. IOVs are inverted vesicles obtained from membranes of human red 
blood cells. In this system, PMCA has the catalytic domains oriented toward the outside 
of the vesicle and maintains the native lipid environment. Isoforms present in human 
erythrocytes are PMCA1 and PMCA4, although hPMCA4 is the most widely expressed 
(80%) [34]. 
2.3. Purification of functional PMCA from human erythrocytes
PMCA was isolated from calmodulin CaM-depleted human erythrocyte membranes 
using a CaM-affinity chromatography column [36]. Briefly, membrane proteins were 
solubilized in a 0.5% C12E10-containing buffer. After centrifugation, the supernatant was 
loaded into a CaM-Sepharose column in the presence of 1 mM Ca2+. The column was 
thoroughly washed with 0.05% C12E10-containing buffer. PMCA was eluted in 20% (w/v) 
glycerol, 0.005% C12E10, 120 mM KCl, 1 mM MgCl2, 10 mM MOPS-K (pH 7.4 at 4°C), 2 
mM EGTA, 2 mM dithiothreitol. No phospholipids were added at any step along the 
purification procedure. Purified PMCA was assayed for protein concentration and 
homogeneity by SDS-PAGE (about 10 μg/ml, single band at Mr 134,000) and stored in 
liquid nitrogen until used. The purification procedure described preserves transport 
activity and the kinetic properties and regulatory characteristics of the enzyme in its 
native milieu [37].
2.4. Measurement of ATPase activity
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PMCA ATPase activity in the samples was measured at 37 ºC by following the release 
of inorganic phosphate from ATP as previously described [38]. Briefly, hPMCA4 was 
resuspended in micelles containing 80 M C12E10 and 38 M DMPC. The determination 
of PMCA activity was performed at 37ºC in media containing 30 mM MOPS (pH 7.4), 
120 mM KCl, 3.75 mM MgCl2, 2 mM ATP, and the amount of CaCl2 to give the desired 
final free Ca2+ concentration. The indicated flavonoid was added to the reaction medium 
at the beginning of the experimental at different concentrations (Table1, Figure 2, 
Figure 3) and the pump activity was measured. For PMCA ATPase activity measured 
with IOVs samples, blanks were included in an assay in the same medium without Ca2+ 
in the presence of 1 mM EGTA (without Ca2+).
Free Ca2+ concentration in the incubation media was estimated using MaxChelator [39], 
a software for determining the free cation concentration in the presence of chelators or 
total metal given a desired free concentration 
(https://somapp.ucdmc.ucdavis.edu/pharmacology/bers/maxchelator/). The PMCA 
activity obtained at 80 M free Ca2+ concentration was used as 100%.
2.5. Determination of phosphorylated intermediates
Phosphorylated intermediates (EP) were measured as the amount of acid-stable 32P 
incorporated in the enzyme from [32P] ATP after stopping the reaction with an ice-cold 
solution containing 10% trichloroacetic acid. The determination of EP was performed at 
25ºC in media 30 mM MOPS (pH 7.4) buffer containing 120 mM KCl, 3.75 mM MgCl2, 
80 M C12E10, 38 M PC, 30 M ATP, and the amount of CaCl2 required to give the 
final free Ca2+ concentration of 80 M. The flavonoid indicated was added to the 
reaction medium at the beginning of the experiment (100 M gossypin, 25 M 
quercetin; Figure 4). The isolation and quantification of the intermediate was performed 
according to the method described by Echarte et al. [40]. 
  
8
Flavonoids concentrations were selected to be more than 20 times the Ki for the PMCA 
(Table 2).
2.6. Cell culture and overexpression of hPMCA4
HEK293T cells were cultured as monolayers in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% (v/v) FBS and 1% (v/v) antibiotic/antimycotic solution 
at 37°C in a 5% CO2 atmosphere. Cells were transfected with EGFP-hPMCA4b [41] 
using Lipofectamine LTX with Plus Reagent as described in the manufacturer’s protocol 
(Thermo-Fisher Scientific). HEK293T-mock cells (cells transfected with the empty 
vector) were cultured in parallel as control of expression and activity. hPMCA4 
overexpression was verified by Western blot.
2.7. Kinetics of Ca2+ transport in HEK293T cells
HEK293T cells were seeded on sterile 96-well black-walled, clear-bottom plates 
(Corning Inc., Corning, NY, USA) at a density of 1.5 x 104 cells/well. After 18 h, cells 
were transfected with mock or EGFP-hPMCA4b plasmid, and Ca2+ transport was 
assayed 18 h after transfection using Fluo4-AM. Cells were loaded for 1 h at 37°C with 
5 μM of the fluorophore in reaction buffer (RB) composed of 10 mM Hepes (pH 7.4), 
120 mM choline chloride, 5 mM KCl, 1 mM MgCl2 and 5 mM D-glucose. This buffer 
contained choline chloride instead of NaCl to minimize the effect of the Ca2+/Na+ 
exchanger. After dye loading, the plates were washed twice and 100 l of RB was 
added to the samples. Cells were then incubated with 25 M quercetin, 50 M 
gossypin, DMSO (vehicle) or RB during 30 min. The flavonoids concentrations used 
were the ones at which cells maintained their adherence and shape. Fluorescence was 
measured at λ excitation 485±20 nm (λ emission: 528±20 nm) in a fluorometric plate 
reader (Synergy HT. Biotek, BioTek Instruments Inc., Winooski, VT, USA). 
Fluorescence signals were analyzed using software Gen 5.2.01. Stable baseline values 
were established for at least 3 min, and then 15 µl of RB with 1 M TG was added. 
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Therefore, the fluorescence was recorded for at least 4 min, and then 15 µl of RB with 1 
mM CaCl2 was added. TG specifically inhibits the SERCA, which induces depletion of 
ER Ca2+ stores and the activation of SOCs [42]. Traces showing the time course of 
fluorescence intensity were normalized to the baseline and expressed as relative 
cytosolic Ca2+ ([Ca2+]CYT). The area under curve (AUC) is the integral of the rise in 
[Ca2+]CYT from the moment of compound addition (TG or Ca2+) until basal levels are 
reached (TG) or until the end of Ca2+ measurements. Activity of hPMCA4 was 
calculated using the AUCs and equation 1, as described by Dalghi et al. [43]. 
            Eq. 1𝑃𝑀𝐶𝐴4 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =  
(𝐴𝑈𝐶𝑚𝑜𝑐𝑘,𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 ‒  𝐴𝑈𝐶𝑃𝑀𝐶𝐴4,𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡)
(𝐴𝑈𝐶𝑚𝑜𝑐𝑘,𝑣𝑒ℎ ‒  𝐴𝑈𝐶𝑃𝑀𝐶𝐴4,𝑣𝑒ℎ)
Flavonoids fluorescence did not interfere with FLUO4 fluorescence (data not shown).
2.8. Detection of PMCA expression in HEK293T cells
Cells were lysed in RIPA lysis buffer (150 mM NaCl, 50 mM Tris pH 7.4, 5 mM EDTA, 
1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate) 
supplemented with protease inhibitors (10 μg/ml aprotinin and 4 μg/ml leupeptin). Cells 
were then centrifuged at 5000 g during 15 min and the supernatant was collected. 
Protein content in the supernatant was determined using the Bradford protein assay 
[44]. Samples were separated using a 10% SDS gel (50 μg protein per lane in sample 
buffer containing 150 mM Tris-HCl (pH 6.5 at 14°C), 5% SDS, 5% DTT, 10% glycerol, 
and bromophenol blue), and proteins were transferred to a PVDF blot membrane 
(BioRad). After blocking, the blot was incubated with the anti-PMCA primary mouse 
monoclonal antibody 5F10 [45] (1:2000 dilution; Pierce) overnight at 4°C. Anti-mouse 
IgG, horseradish peroxidase-linked whole antibody (1:20000; Amersham, 
Buckinghamshire, UK) was used as the secondary antibody. Immunoreactive bands 
were visualized using the enhanced chemiluminescence method (Kalium Technologies, 
Buenos Aires, Argentina). Digital images were obtained and quantified using the 
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ImageQuant LAS 500 chemiluminescence CCD camera (GE Healthcare Life Sciences, 
Marlborough, MA, USA). 
2.9. Detection of flavonoids in HEK293T cells 
Cells cultured on coverslips were incubated with DMSO, 25 M quercetin or 50 M 
gossypin for 30 min in RB at 37°C. Cells were then fixed with 2% w/v formaldehyde in 
PBS for 10 min and nuclei were stained with 1 μM Hoechst. Coverslips were mounted 
with fluorescence mounting medium (Dako, Santa Clara, CA, USA) on glass slides and 
observed on a FluoView 1000 confocal microscope (Olympus, Tokyo, Japan). Flavonoid 
fluorescence was observed with excitation at 490 nm and emission at 510 nm. 
2.10. Data analysis
Theoretical equations were fitted to experimental data by nonlinear regression based on 
the Gauss-Newton algorithm and using the commercial software Excel and Sigma-Plot 
12.0 for Windows. 
Equation 2 was used when the experimental data from Ca2+-ATPase activity vs [Ca2+] 
(section 3.2) were described by the rectangular hyperbola
Eq. 2𝑣 =  
𝑉𝑚𝑎𝑥 [𝐶𝑎2 + ] 
𝐾0.5 +  [𝐶𝑎2 + ]
where Vmax is the Ca2+-ATPase activity when the Ca2+ concentration ([Ca2+]) tends to 
infinity, and K0.5 represents the [Ca2+] at which the half-maximum effect is achieved.
One-way analysis of variance (ANOVA) followed by Bonferroni post-test was performed 
using GraphPad Prism version 6.00 for Windows, GraphPad Software (San Diego, CA, 
USA). A probability (P) value < 0.05 was considered statistically significant.
3. Results
3.1. Inhibition of PMCA Ca2+-ATPase activity by natural flavonoids 
The effects of different natural flavonoids on Ca2+-ATPase activity were evaluated using 
two in vitro models: IOVs and purified hPMCA4.
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Table 1 summarizes the Ca2+-ATPase activity obtained in the presence of each 
flavonoid at 100 M for purified hPMCA4 and IOV systems. The activity is expressed as 
the percentage of the value measured in the absence of flavonoids (presence of 
DMSO). Flavonoids showing less than 25% inhibition of activity were considered 
inactive. Results show that base structures (chalcone, flavone and flavanone) and all 
flavanones failed to inhibit PMCA activity. For flavones, only apigenin and diosmetin 
showed slight inhibition. In contrast, all three flavonol aglycones tested were able to 
inhibit PMCA, quercetin being the most potent, and gossypin being the most active 
flavonol glycoside. In addition, some flavonoids inhibitory effects were found to be 
higher on purified hPMCA4 than on IOVs, as can be seen for apigenin, diosmetin, 
quercetin, kaempferol and gossypin. Hyperoside, however, was only effective on 
purified hPMCA4.
Figure 2 shows the purified PMCA activity measured at different concentrations of the 
active flavonoids. The best fitting values of the apparent constant of inhibition (Ki) are 
shown in Table 2. 
Results indicate that, in general, an increased number of -OH substitutions in the 
flavone nucleus led to an increase in the inhibitory effect. Consequently, flavonols 
resulted more potent than flavones. Thus, apigenin and diosmetin inhibited hPMCA4 
with very low affinity, which could be related to the absence of the -OH in R3 position. 
Furthermore, gossypin and hyperoside have -OH in position R3’ and R4’, like quercetin, 
but their affinities were lower, which could be caused by the glycosides present in their 
structure. Moreover, the position of the glycoside could generate differences in the 
inhibition related to steric impediments at the interaction site.
As quercetin and gossypin proved to be the most active PMCA inhibitors, the 
subsequent studies were focused on these two flavonols.
3.2. Inhibition of PMCA by quercetin and gossypin regarding Ca2+concentrations
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To evaluate the type of inhibition exerted by these flavonoids on hPMCA4 regarding 
Ca2+, the purified PMCA activity was measured as a function of Ca2+ concentration in 
the presence of different concentrations of quercetin or gossypin (Figure 3A and D, 
respectively). In both cases, experimental data were described by a rectangular 
hyperbola (Eq. 2). The best fitting values of K0.5 for Ca2+ and Vmax were plotted as a 
function of quercetin (Figure 3B and C, respectively) or gossypin (Figure 3E and F, 
respectively).
For quercetin, results show that K0.5 for Ca2+ was not significantly modified (Figure 3B) 
and Vmax decreased (Figure 3C), indicating that quercetin is a non-competitive 
inhibitor with respect to Ca2+. For gossypin, both K0.5  for Ca2+ and Vmax decreased as a 
function of gossypin (Figure 3E and F, respectively), while their relationship did not 
change with flavonoid concentration (inset Figure 3F). These results suggest that 
gossypin is an uncompetitive inhibitor type with respect to Ca2+.
3.3. Effect of quercetin and gossypin on steady state levels of phosphorylated 
intermediates
In order to obtain valuable information of ATP interaction with PMCA, we evaluated the 
effect of quercetin and gossypin on EP. The steady state levels of EP were measured 
during 30 s at 25°C in the absence (control) or in the presence of 25 M quercetin, 100 
M gossypin or 500 M LaCl3. EP level obtained for control was established as 100%. 
LaIII inhibits PMCA activity producing accumulation of E1P [46,47]. Current results show 
that, in presence of quercetin, hPMCA4 was phosphorylated at the same level as in the 
presence of LaIII in conditions where the inhibition of PMCA activity was maximum. In 
contrast, gossypin caused a decrease in PMCA phosphorylation (Figure 4).




To assess whether the effects of quercetin or gossypin observed on the purified 
hPMCA4 could occur in a living cell, the dynamics of cytoplasmic Ca2+ ([Ca2+]CYT) were 
studied in HEK293T cells overexpressing hPMCA4 according to the method previously 
described [43,48]. The dynamics of [Ca2+]CYT were examined by studying the alterations 
in [Ca2+]CYT generated by Ca2+ release from the ER, and by extracellular Ca2+ entry 
through SOCs. A typical time course experiment was conducted which comprised two 
phases: (i) a first phase involving the transient elevation in [Ca2+]CYT generated by the 
addition of 1 µM TG, a SERCA inhibitor that causes Ca2+ release from the ER, and (ii) a 
second phase subsequent to the addition of 1 mM Ca2+ to the external medium, which 
induces an increase in [Ca2+]CYT indicative of SOC activity (Figure 5A).
For each phase, the effect on the dynamics of Ca2+ was quantified as the AUC 
representing the overall [Ca2+]CYT of each phase, so that a more effective mechanism of 
Ca2+ extrusion will be reflected in an overall AUC decrease. The AUC value obtained for 
HEK293T-mock cells was established as 100%. By performing ANOVA analysis on 
these data, we evaluated whether hPMCA4 overexpression affected the AUC compared 
to HEK293T-mock cells. Results show that AUC values for both phases were lower 
when cells overexpressed hPMCA4 (Figure 5B and C), suggesting that the Ca2+ 
extrusion mechanism was more effective in HEK293T-hPMCA4 cells. hPMCA4 
overexpression was corroborated by western blot (Figure 5D).
To evaluate the effect of quercetin and gossypin on the dynamics of [Ca2+]CYT, 
HEK293T-mock and HEK293T-hPMCA4 cells were treated with 25 M quercetin, 50 M 
gossypin or vehicle for 30 minutes. The AUC values obtained for both phases were 
evaluated for HEK293T-mock and HEK293T-hPMCA4 cells in the presence of the 
different treatments. The AUC value obtained for HEK293T-mock cells treated with 
vehicle was established as 100%. By performing ANOVA on these data, we evaluated 
whether treatments affected the behavior of HEK293T-mock and HEK293T-hPMCA4 
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cells. Treatments revealed no significant effect on HEK293T-mock cells, which indicates 
that, in these conditions, Ca2+ release from the ER, Ca2+ entry through SOCs and Ca2+ 
removal from the cytosol remained unaltered. However, results obtained with HEK293T-
hPMCA4 cells show that quercetin and gossypin treatments induced an increase in 
AUC values vs. vehicle treatment, suggesting that Ca2+ release from the ER or the 
cytosol was less effective in flavonoid-treated HEK293T-hPMCA4 cells (Figure 6). In 
order to evaluate to what extent this effect was due to hPMCA4, PMCA activity was 
obtained using equation 1 for both phases (Table 3). For the first phase, the control 
value for hPMCA4 activity was 100 ± 10%, whereas the values obtained for the 
treatment with quercetin and gossypin were 34 ± 14% and 10 ± 7%, respectively; 
however, Ca2+ extrusion mediated by hPMCA4 decreased ~66% and ~90%. 
For the second phase, the control value for hPMCA4 activity was 100 ± 2%, whereas 
the values obtained for the treatment with quercetin and gossypin were 63 ± 2% and 34 
± 3%, respectively; however, Ca2+extrusion mediated by hPMCA4 decreased ~37% and 
~66%.
Finally, flavonoid fluorescence was assessed to determine the incorporation of these 
flavonoids in HEK293T cells. When cells were treated with 25 M quercetin or 50 M 
gossypin for 30 minutes, green fluorescence was observed inside the cells under the 
confocal scanning microscope, indicating that the two flavonoids were incorporated into 
HEK293T cells. In contrast, cells incubated with DMSO (vehicle control) showed no 
intracellular fluorescence (Figure 7). Images show that quercetin was widely distributed 





The present study reveals an inhibitory effect of natural flavonoids on the human 
isoform PMCA4 in different system levels: vesicles, isolated protein and living cells. Our 
results indicate that hPMCA4 activity is inhibited by some natural flavonoids both in 
IOVs and isolated protein. Apigenin, diosmetin, quercetin, kaempferol and gossypin 
showed an inhibitory effect on purified hPMCA4 which was higher than on IOVs, while 
hyperoside was only effective on purified hPMCA4 (Table 1). The current findings also 
show that a double bond between C2-C3 in the structure is key to flavonoid activity. 
Thus, chalcones and flavanones were not active, as they lack the double bond. Type, 
number and position of the substituents in the flavone nucleus are also determinants of 
activity. Consequently, hydroxylation in positions R5 and R7 of the A ring induced low 
inhibition (apigenin and diosmetin). Also, hydroxylation in R3 of the C ring had a 
moderate effect on activity (galangin vs chrysin, apigenin vs chrysin), while 
hydroxylation in positions R3’ and R4’ of the B ring significantly increased inhibition 
(quercetin and gossypin). On the other hand, glycosylation in position R7 (rutin and 
hyperoside) prevented inhibition in IOVs. These findings are in agreement with previous 
studies related to the effects of flavonoids on H+,K+-ATPase and Na+,K+-ATPase [11]. 
Conversely, studies on SERCA have revealed that the inhibitory activity of a flavonoid is 
not affected by hydroxylation in the B ring but does depend on hydroxylation in the A 
and C rings [9].
Quercetin and gossypin were the most potent inhibitors, as they inhibited the purified 
hPMCA4 with high apparent affinity (Ki of 0.34 ± 0.01 and 4.8 ± 0.2 M, respectively; 
Table 2). Both flavonoids have hydroxylation in R3’ and R4’ positions of the B ring; 
however, gossypin has a sugar in position 8’ of the ring A, which could generate 




When Ca2+-ATPase activity was measured as a function of quercetin (Figure 2A and 
B) or gossypin (Figure 2C) concentration, gossypin showed a hyperbolic inhibition 
curve, whereas quercetin exhibited a sigmoidal-shaped inhibition curve with Hill 
coefficient>1. This result indicates that quercetin inhibition was cooperative and 
suggests that hPMCA4 could have more than one site for quercetin binding. This 
behavior has been reported previously for other P-ATPases [23].
In turn, studies on flavonoids inhibitory effects regarding Ca2+ concentrations revealed 
that quercetin behaves as a non-competitive inhibitor for Ca2+ ‒that is, K0.5 for Ca2+ 
unaltered and Vmax reduced ‒, which suggests that quercetin binds to PMCA 
somewhere other than the Ca2+ site (Figure 3A, B and C). Also, this flavonoid induced 
an increase in phosphorylated intermediates, indicating that quercetin may interact with 
phosphorylated conformations, stabilize them, and prevent hPMCA4 dephosphorylation 
(Figure 4). Quercetin could interact with hPMCA4 through the nucleotide binding site 
after PMCA is phosphorylated by ATP. This assumption is in line with the fact that the 
phosphorylated intermediates ‒E1P and E2P‒ have nucleotide binding sites for ADP 
and ATP, respectively [49]. A further possibility is that the interaction occurs through a 
different site.
On the other hand, our results demonstrate that gossypin behaves as a non-competitive 
inhibitor for Ca2+ (Figure 3D, E and F; K0.5 for Ca2+ and Vmax reduced and their 
relationship unaltered by flavonoid concentration), which suggests that gossypin may 
bind to the E1Ca conformation. This result is consistent with the fact that gossypin 
reduced the amount of phosphorylated intermediates by interfering with the binding of 
ATP (Figure 4). Therefore, we propose that gossypin binds to the E1Ca conformation 
through an interaction with the ATP binding site. Taken together, these results suggest 
that quercetin and gossypin inhibit hPMCA4 through different mechanisms, probably 
due to their structural differences. These findings are consistent with previous reports 
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showing flavonoids to interact with ATP binding sites [23,50]. However, the possibility 
that quercetin might interact with another site of the pump cannot be ruled out. 
Furthermore, identifying the generic modes of action with other target enzymes may 
help understand the molecular mechanism by which flavonoids inhibit the PMCA. 
Therefore, future studies should aim to elucidate the kinetic/structural mechanism by 
which flavonoids inhibit the PMCA.
In order to evaluate whether the flavonoid effects observed in isolated systems could 
occur in living cells, we studied the PMCA activity by measuring the dynamics of 
[Ca2+]CYT in HEK293T cells. When Ca2+ penetrates the cytoplasm, either from 
intracellular stores or from the extracellular medium, there is an increase of cytoplasmic 
Ca2+ which is removed by the Na+/Ca2+ exchanger and the PMCA, exported into the ER 
through the SERCA and into the mitochondria, and chelated by cytosolic proteins [51]. 
All these events allow to reestablish stationary [Ca2+]CYT levels after a stimulus. In our 
model, we needed to enhance the role of PMCA in Ca2+ extrusion, thus SERCA activity 
was inhibited using TG, and the Ca2+/Na+ exchanger activity was minimized avoiding 
the presence of Na+ in the extracellular media. However, under these experimental 
conditions, other mechanisms can produce Ca2+ extrusion besides PMCA. Since there 
are no specific inhibitors for the pump, we decided to overexpress hPMCA4 in the 
HEK293T cell line (HEK293T-hPMCA4 cells). In this case, results show that Ca2+ 
extrusion was more effective in HEK293T-hPMCA4 cells (Figure 5), which agrees with 
the presence of more enzyme units in the cells. These findings were previously 
described for the PMCA2 isoform [43]. 
Using this system to evaluate flavonoid effects on hPMCA4, we observed that quercetin 
and gossypin treatments showed no effect on the dynamics of [Ca2+]CYT in HEK293T-
mock cells, which indicates that the processes of Ca2+ release from the ER promoted by 
TG, Ca2+ entry through SOCs and Ca2+ removal from the cytosol remain unaffected in 
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these conditions (Figure 6). These findings in turn suggest that the endogenous 
transport systems involved in these processes were not affected. In HEK293T cells, 
endogenous PMCA is mainly PMCA1 isoform [52], which may mean that flavonoids do 
not inhibit this particular isoform. On the other hand, we observed that quercetin and 
gossypin treatments showed a significant inhibitory effect on the dynamics of [Ca2+]CYT 
in HEK293T-hPMCA4 cells, indicating that Ca2+ removal from the cytosol was inhibited 
when hPMCA4 was overexpressed (>AUC values, Figure 6). In addition, studies on the 
extent to which these effects were due to hPMCA4 suggest that quercetin and gossypin 
treatments induced the inhibition of hPMCA4 activity in these experimental conditions 
(Table 3).
According to the results obtained with purified hPMCA4, the interaction of quercetin and 
gossypin with PMCA could occur in cytoplasmic domains (e.g. ATP binding site), which 
hints at flavonoids ability to cross the plasma membrane. Confocal microscopy assays 
performed on gossypin and quercetin capability to enter the cell revealed that quercetin 
was widely distributed in the cytoplasm and nucleus, whereas gossypin was 
accumulated mainly in the cytoplasmic-perinuclear region of the cell (Figure 7). 
Consequently, these flavonoids may be thought to interact with cytoplasmic domains of 
PMCA in the cells. In brief, the inhibitory effect of quercetin and gossypin observed with 
purified hPMCA4 could be comparable to that occurring in living cells. However, and 
considering the complexity of cellular systems, other underlying mechanisms cannot be 
ruled out.
Some reports suggest that quercetin inhibits cell migration [53,54], which is an essential 
cellular process involved in a variety of biological events such as embryonic 
development, angiogenesis, inflammation and in pathological conditions such as cancer 
metastasis [55]. This effect could occur at least in part by perturbing microtubule and 
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actin polymerization [54–56]. These cytoskeleton alterations could be affected by PMCA 
activity.
Our group previously reported a regulatory mechanism of PMCA activity by the actin 
cytoskeleton, showing that actin differentially regulates PMCA activity depending on its 
polymerization state: short actin oligomers increase PMCA activity while F-actin inhibits 
it [43,57,58]. Therefore, quercetin interacts with actin and induces depolymerization, 
which could be activated by PMCA although the inhibitory effect observed in the current 
study is more important. On the other hand, it has been shown that acetylated tubulin 
can bind and inhibit PMCA activity [59]; however, the effect of changes in microtubule 
dynamics on PMCA have not been addressed yet. Since quercetin inhibits microtubule 
polymerization, the tubulin pool may increase in the cell so that tubulin forms a complex 
with the pump and inhibits it. Our results in cells show that quercetin inhibited PMCA 
activity, an effect which might involve alterations in microtubule functionality. 
In conclusion, this work reveals a novel inhibition mechanism through which flavonoids 
affect PMCA activity, which may occur in living cell systems. Our results indicate that 
some natural flavonoids inhibit purified hPMCA4 with different potency, which could be 
mainly due to the presence of -OH groups in R3’ and R4’ position of the B ring. 
Quercetin and gossypin were the most potent inhibitors, although their inhibition 
mechanisms seemed to be different; in the concentration range studied, quercetin did 
not prevent ATP binding whereas gossypin did. However, PMCA inhibition by quercetin 
may be independent of the ATP binding site. Moreover, both flavonoids were 
incorporated into the cells and PMCA activity was inhibited, suggesting that the effects 
observed on isolated systems may occur in a more complex structure like a whole cell.
Further studies are required to understand Ca2+ homeostasis alterations involving 
natural flavonoids in malignant cells and their relationship with PMCA. The 
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characterization of these mechanisms will allow us to develop new drugs for the 
prevention and/or treatment of diseases like cancer.
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Table 1. Effect of flavonoids on Ca2+-ATPase activity in IOVs and purified PMCA. 
The table describes the name, classification and structure of flavonoids evaluated. Also, 
it shows the values of Ca2+-ATPase activity obtained in the presence of 100 M of each 
flavonoid for IOVs and PMCA purified. Activity measurements were carried out at 37°C 
in a reaction medium containing 50 μg/ml vesicles (IOVs) or 0.8 μg/ml purified PMCA 
and 100 μM free Ca2+ concentration. PMCA activity was related to the activity in the 
presence of DMSO (100%). Results are expressed as the mean ± S.E. (n≥3).
Table 2. Ki values of the most active flavonoids.
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Table 3. Effect of quercetin and gossypin on hPMCA4 activity in HEK293T cells. 
Activity values were obtained from data from Figure 6 as described in Materials and 
Methods.
FIGURE LEGENDS
Figure 1. Simplified kinetic model of the PMCA. 
Figure 2. Effect of flavonoid concentration on PMCA Ca2+-ATPase activity. Ca2+-
ATPase activity was measured using purified PMCA in the presence of increasing 
amounts of flavonols (A and B), flavonol glucosydes (C) and flavones (D). 
Measurements were carried out at 37°C in a reaction medium containing 0.8 μg/ml 
PMCA reconstituted in DMPC/C12E10 mixed-micelles (10 μg/ml and 70 μg/ml, 
respectively), 3.75 mM MgCl2, 2 mM ATP and the CaCl2 required to give concentrations 
of 100 μM [Ca2+]free. Experimental data were related to PMCA activity measured in the 
presence of DMSO. Data are expressed as the mean ± S.E. of 3 independent replicates 
in each experiment. Continuous lines in panels represent a hyperbolic decreasing 
function and discontinuous lines represent a Hill function.
Figure 3. Effect of Ca2+ on flavonoid inhibition of PMCA Ca2+-ATPase activity. 
Ca2+-ATPase activity was measured at different [Ca2+] in the presence of different 
concentrations of quercetin (A) and gossypin (D), phosphatidylcholine, and the amount 
of CaCl2 required to give the desired final [Ca2+]free. In panel A, quercetin concentrations 
were: 0 ( ); 0.17 ( ); 0.25 ( ); 0.31 ( ); 0.38 ( ) and 0.42 ( ) M. In panel D, 
gossypin concentrations were: 0 ( ), 1 ( ), 3 ( ), 5 ( ), and 10 ( ) M. 
Measurements were carried out in a reaction medium containing 0.8 μg/ml PMCA, 120 
mM KCl, 30 mM MOPS-K (pH 7.4 at 37 ºC), 3.75 mM MgCl2, 70 μg/ml C12E10, 10 μg/ml. 
Data are expressed as the mean ± S.E. of 3 independent replicates in each experiment. 
Continuous lines represent rectangular hyperbolas. Best fitting values of K0.5 and Vmax 
were obtained from A and D. K0.5 values were plotted as a function of quercetin (B) and 
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gossypin (E). Vmax values were plotted as a function of quercetin (C) and gossypin (F). 
Inset in F: K0.5/Vmax ratio as a function of gossypin concentration.
Figure 4. Quantification of phosphoenzyme in the presence of quercetin and 
gossypin. PMCA phosphorylation measurements were carried out in steady state at 
25°C in a reaction medium containing 1μg/ml PMCA reconstituted in DMPC/C12E10 
mixed-micelles (10 μg/ml and 70 μg/ml, respectively), 3,75 mM MgCl2, 30 μM ATP, the 
CaCl2 required to give 100 μM of free Ca2+ in the absence (control) or in the presence of 
500 M LaIII, 25 M quercetin (QT) or 100 M gossypin (Gos) during 30 seconds. The 
EP level obtained for control was established as 100%. EP levels significantly different 
from controls (** p> 0.01; *** p> 0.001, one-way ANOVA with Bonferroni post-tests).
Figure 5. Dynamics of cytosolic Ca2+ in HEK293T cells. Pattern of Ca2+ transients 
in HEK293T cells induced by TG and SOCs. (A) Representative traces of the time 
course of [Ca2+]CYT in HEK293T cells transiently overexpressing hPMCA4 or transfected 
with empty vector (control) (18 h post-transfection) upon addition of 1 μM TG in nominal 
free Ca2+ medium and after adding Ca2+ (1 mM) to the extracellular solution. The curves 
are representative of three independent experiments. B. Area under the curve of the 
[Ca2+]CYT signal after TG (1 μM) addition (first phase). C) Area under the curve of the 
[Ca2+]CYT signal after addition of Ca2+ (1 mM) to the extracellular solution (second 
phase). Significant differences from controls (*p<0.05 and ****p<0.0001, one-way 
ANOVA). AUC were calculated as indicated in Materials and Methods. (D) Western blot 
analysis was performed with whole-cell lysates using the 5F10 antibody.
Figure 6. Effect of quercetin and gossypin on hPMCA4. Areas under the curve of 
the [Ca2+]CYT signal were obtained from similar experiments to Figure 5 where cells 
were incubated at 37°C in the presence of DMSO (vehicle, Veh), (A and B) 25 M 
quercetin (QT) or (C and D) 50 M gossypin (Gos) during 30 minutes.  AUC of the 
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[Ca2+]CYT after addition of (A and C) TG (first phase), and (B and D) Ca2+ (second 
phase). AUC were calculated as indicated in Materials and Methods. Significant 
differences from controls (*p<0.05, **p<0.01, ***p<0.001, one-way ANOVA). Data were 
obtained from three independent experiments performed in n=6.
Figure 7. Intrinsic fluorescence of quercetin or gossypin. HEK293T cells were 
treated for 30 min with 25 M quercetin, 50 M gossypin or DMSO (control) according 
to Materials and Methods. Fluorescence was observed in a confocal microscope.
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Flavone H H H H H H H H
6-methylflavone H H CH3 H H H H H
Chrysin (5,7-Dihydroxyflavone) H OH H OH H H H H
Apigenin (4′,5,7-Trihydroxyflavone) H OH H OH H H H OH
Diosmetin (3’,5,7-Trihydroxy-4′-methoxyflavone) H OH H OH H H OH OCH3
Galangin (3,5,7-Trihydroxyflavone) OH OH H OH H H H H
Kaempherol (3,4′,5,7-Tetrahydroxyflavone) OH OH H OH H H H OH
Quercetin (3,3′,4′,5,7-Pentahydroxyflavone) OH OH H OH H H OH OH
Rutin (3,3′,4′,5,7-Pentahydroxyflavone 3-rutinoside) O-β-Rt OH H OH H H OH OH
Hyperoside (3,3′,4′,5,7-Pentahydroxyflavone 3-D-galactoside) O-β-Gal OH H OH H H OH OH
Gossypin (3,3′,4′,5,7,8-Hexahydroxyflavone 8-glucoside) OH OH H OH O-β-Glc H OH OH
Flavanone H H H H H H H H
Hesperetin (3′,5,7-Trihydroxy-4′-methoxyflavanone) H OH H OH H H OH OCH3
Hesperidin (3′,5,7-Trihydroxy-4′-methoxyflavanone 7-rutinoside)             H OH H O-β-Rt H H OH OCH3
Naringin (4′,5,7-Trihydroxyflavanone 7-rhamnoglucoside) H OH H O-β-Nh H H H OH
Chalcone
Hesperidin methyl chalcone
* Ca2+-ATPase activity at 100 M of flavonoid
Sugar moieties: glucose (Glc), neohesperidose (O-L Rhamnosyl-(1/2)-glucose, Nh), rutinose (OL Rhamnosyl-(1/6)-glucose, Rt), galactose (Gal)






116.6 ± 0.1 94.6 ± 1.7
61.0 ± 5.1 45.2 ± 4.3








116.5 ± 0.8 109.0 ± 9.9




















(mean ± S.E.M. in % of control)Treatment
First phase Second phase
Vehicle (0.1% DMSO) 100 100
Quercetin 25 μM, 30 min 34 ± 14 63 ± 2




Apigenin (4′,5,7-Trihydroxyflavone) 94.8 ± 7.9
Hyperoside (3,3′,4′,5,7-Pentahydroxyflavone 3-D-galactoside) 88.7 ± 5.1
Kaempferol (3,4′,5,7-Tetrahydroxyflavone) 88.5 ± 5.4
Diosmetin (3’,5,7-Trihydroxy-4′-methoxyflavone) 54.0 ± 2.9
Gossypin (3,3′,4′,5,7,8-Hexahydroxyflavone 8-glucoside) 4.8 ± 0.2
Quercetin (3,3′,4′,5,7-Pentahydroxyflavone) 0.34 ± 0.01
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